agreed, $14 was a gift, $13.5 is also not bad. It might hold up if they can get a deal, but stubborn IMGN wants to try and develop on their own, something they have failed to do for 25 years. Maybe they now have the tools, people and $, but it will take 2-3 years before shareholders know. Still, hats off, I puked out over 20,000 shares and I don't even want to think about the math, but at $14 it's a big number.
I let fear and irritation get the best of me and made a bad sale. The small trial results do look good, but I won't make the mistake of believing them now. When Dan buys some stock let me know. Remember that early results for the Endocyte folar targeting small cel ADC also looked promising and in fact MRK invested $200MM in their small molecule. The drug failed in larger trials.
BB's investment is encouraging, maybe they have something. Maybe they can find an investor to move the drug forward. They should not try to do this on their own based on their track record, but maybe they have some better clinical trial design people now; the GENZ exec seems impressive. This might require some combo trials for max results, but maybe the larger phase II will give them enough for a limited approval. Overall it's a big + I just don't trust IMGN management, been burned too many times and seen them fail too many times over 25 years.
Next stop/first resistance is around $10.5 and there's not much there. Then $11. IMO not advice and just based on technicals and common sense (JNJ paid $12.25 hello).
amen to that, short cost is high! There's no reason this stock should not be back to $6+ today except for shorting.
yes, it's the CEO:BOD payola, back scratching and circle jrk deal. Great job of stealing and destroying shareholder $$. Not sure why I continue to own this stock. Should have swapped it all into ACHN earlier this week, but that would be greedy of me.
I was referring to the need to reduce expenses since my cash is burning. On the + side, I bought some ACHN and sold puts after the JNJ investment and price decline and that's working out well.
when Jack joined the BOD, the stock price was over $100. It's time for him to resign ARNA!
You should be happy he's gone, ARNA investors are jealous! Now, if we can just get him to resign from ARNA...if Jack every invests a dime his own capital (really ARNA investor capital) in any company, let everyone know. Jack has never bought a share of ARNA stock and is a terrible CEO IMO.
amen, totally agree with the PCYC comparison, but maybe a little less upside unless they have more assets in the early pipeline. I bought only because of the JNJ investment and price drop, need to get to know more before deciding about the LT. Ready fire, aim.
agreed, bought more stock today and sold a few puts. USO is green, stocks still down and recently down much more than USO thanks to the shorts. BUY IMO.
Sell calls when a stock is overbought, not oversold. I sold the June 7.5 calls a few weeks ago, which look to be expiring worthless. Not planning to sell any calls at this price level. IMO of course.
I thinks charts are very useful for those skilled in reading them. BBEP is very oversold and I continue to average down based on their hedges and my belief that oil will not stay below the cost of drilling for years. Maybe a few more months, maybe another 6-12 months, but BBEP should be OK and the div is high, coverage ratio is high. Don't let the liars bring you down.
it's a chicken and egg thing. If the stock dist rate is not above the bond rates, investors will prefer the bonds or preferred since they have less default risk.
Just 2 short posters with thumbs down? I would think Chanos can afford more MB activity based on his articles, media, press, etc.
really, investing $225MM is a downer? When did $225MM become a disappointing amount of $? What a stupid point IMO.